119 related articles for article (PubMed ID: 11798912)
1. [The biological function of platelet-derived growth factor-BB in the osteoblast-osteoclast co-culture system].
Zhang Z; Chen J; Jin D
Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(7):425-8. PubMed ID: 11798912
[TBL] [Abstract][Full Text] [Related]
2. [The effects of platelet-derived growth factor-AA on the osteoclasts].
Chen J; Zhang Z; Jin D; Wu D
Zhonghua Wai Ke Za Zhi; 2000 Jun; 38(6):465-8, 27. PubMed ID: 11832087
[TBL] [Abstract][Full Text] [Related]
3. Platelet-derived growth factor (PDGF)-BB stimulates osteoclastic bone resorption directly: the role of receptor beta.
Zhang Z; Chen J; Jin D
Biochem Biophys Res Commun; 1998 Oct; 251(1):190-4. PubMed ID: 9790928
[TBL] [Abstract][Full Text] [Related]
4. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.
van't Hof RJ; Ralston SH
J Bone Miner Res; 1997 Nov; 12(11):1797-804. PubMed ID: 9383684
[TBL] [Abstract][Full Text] [Related]
5. Autocrine and paracrine nitric oxide regulate attachment of human osteoclasts.
Yaroslavskiy BB; Li Y; Ferguson DJ; Kalla SE; Oakley JI; Blair HC
J Cell Biochem; 2004 Apr; 91(5):962-72. PubMed ID: 15034931
[TBL] [Abstract][Full Text] [Related]
6. Platelet-derived growth factor enhances bone cell replication, but not differentiated function of osteoblasts.
Hock JM; Canalis E
Endocrinology; 1994 Mar; 134(3):1423-8. PubMed ID: 8119182
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption.
Vitté C; Fleisch H; Guenther HL
Endocrinology; 1996 Jun; 137(6):2324-33. PubMed ID: 8641182
[TBL] [Abstract][Full Text] [Related]
8. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor BB secreted from osteoclasts acts as an osteoblastogenesis inhibitory factor.
Kubota K; Sakikawa C; Katsumata M; Nakamura T; Wakabayashi K
J Bone Miner Res; 2002 Feb; 17(2):257-65. PubMed ID: 11811556
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived growth factor stimulates the synthesis of interleukin-6 in cells of the osteoblast lineage.
Franchimont N; Canalis E
Endocrinology; 1995 Dec; 136(12):5469-75. PubMed ID: 7588297
[TBL] [Abstract][Full Text] [Related]
11. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity.
Collin-Osdoby P; Oursler MJ; Rothe L; Webber D; Anderson F; Osdoby P
J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630
[TBL] [Abstract][Full Text] [Related]
12. Human osteoclast maturation from bone marrow cells co-cultured with osteoblast from ethmoid sinus.
Ishino T; Yajin K; Takeno S; Furukido K; Takumida M; Hirakawa K
Rhinology; 2003 Mar; 41(1):49-53. PubMed ID: 12677741
[TBL] [Abstract][Full Text] [Related]
13. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption.
Löwik CW; Nibbering PH; van de Ruit M; Papapoulos SE
J Clin Invest; 1994 Apr; 93(4):1465-72. PubMed ID: 8163651
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide enhances osteoclastogenesis possibly by mediating cell fusion.
Nilforoushan D; Gramoun A; Glogauer M; Manolson MF
Nitric Oxide; 2009 Aug; 21(1):27-36. PubMed ID: 19389479
[TBL] [Abstract][Full Text] [Related]
15. Regulation of human bone sialoprotein gene transcription by platelet-derived growth factor-BB.
Mezawa M; Araki S; Takai H; Sasaki Y; Wang S; Li X; Kim DS; Nakayama Y; Ogata Y
Gene; 2009 Apr; 435(1-2):80-7. PubMed ID: 19393184
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide promotes infectious bone resorption by enhancing cytokine-stimulated interstitial collagenase synthesis in osteoblasts.
Lin SK; Kok SH; Kuo MY; Lee MS; Wang CC; Lan WH; Hsiao M; Goldring SR; Hong CY
J Bone Miner Res; 2003 Jan; 18(1):39-46. PubMed ID: 12510804
[TBL] [Abstract][Full Text] [Related]
17. Total coumarins from fruits of Cnidium monnieri inhibit formation and differentiation of multinucleated osteoclasts of rats.
Qin LP; Zhang QY; Tian YP; Zheng HC; Haung M; Huang BK
Acta Pharmacol Sin; 2003 Feb; 24(2):181-6. PubMed ID: 12546728
[TBL] [Abstract][Full Text] [Related]
18. Osteoclasts control osteoblast chemotaxis via PDGF-BB/PDGF receptor beta signaling.
Sanchez-Fernandez MA; Gallois A; Riedl T; Jurdic P; Hoflack B
PLoS One; 2008; 3(10):e3537. PubMed ID: 18953417
[TBL] [Abstract][Full Text] [Related]
19. Osteoblast-mediated effects of zinc on isolated rat osteoclasts: inhibition of bone resorption and enhancement of osteoclast number.
Holloway WR; Collier FM; Herbst RE; Hodge JM; Nicholson GC
Bone; 1996 Aug; 19(2):137-42. PubMed ID: 8853857
[TBL] [Abstract][Full Text] [Related]
20. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
Hill PA; Reynolds JJ; Meikle MC
Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
